{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T09:07:40Z","timestamp":1767172060361,"version":"build-2238731810"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Academician Li Lianda Workstation Special Fund","award":["JY2023002"],"award-info":[{"award-number":["JY2023002"]}]},{"name":"reclinical Study of a Topical Anti-Acne Chemical Drug (Class 2) with Lipid Secretion-Inhibiting Activity - Pharmacodynamic Evaluation of Compound C Ointment","award":["NLTS2025004"],"award-info":[{"award-number":["NLTS2025004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02656-w","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T15:13:15Z","timestamp":1752505995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiomics analysis revealed the regulatory role of chenodeoxycholic acid in fatty acid metabolism and lipid homeostasis"],"prefix":"10.1186","volume":"24","author":[{"given":"Lishuang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuman","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junxiao","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"2656_CR1","doi-asserted-by":"publisher","first-page":"726261","DOI":"10.3389\/fcell.2021.726261","volume":"9","author":"MF RENNE","year":"2021","unstructured":"Renne MF, Hariri H. Lipid Droplet-Organelle contact sites as hubs for fatty acid metabolism, trafficking, and metabolic channeling [J]. Front Cell Dev Biology. 2021;9:726261.","journal-title":"Front Cell Dev Biology"},{"key":"2656_CR2","doi-asserted-by":"crossref","unstructured":"Li X, Bi X. Integrated control of fatty acid metabolism in heart failure [J]. Metabolites. 2023;13(5):615.","DOI":"10.3390\/metabo13050615"},{"key":"2656_CR3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2147\/DMSO.S395053","volume":"16","author":"M SHI","year":"2023","unstructured":"Shi M, Hu B, Hong Y, et al. Deep sea water inhibited pancreatic \u03b2-Cell apoptosis and regulated glucose homeostasis by affecting lipid metabolism in db\/db mice [J]. Diabetes Metabolic Syndrome Obesity: Targets Therapy. 2023;16:245\u201358.","journal-title":"Diabetes Metabolic Syndrome Obesity: Targets Therapy"},{"issue":"1","key":"2656_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.3390\/ijms16010924","volume":"16","author":"C HUANG","year":"2015","unstructured":"Huang C. Lipid metabolism, apoptosis and cancer therapy [J]. Int J Mol Sci. 2015;16(1):924\u201349.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2656_CR5","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S BELORIBI-DJEFAFLIA","year":"2016","unstructured":"Beloribi-Djefaflia S, Vasseur S, Guillaumond F. Lipid metabolic reprogramming in cancer cells [J]. Oncogenesis. 2016;5(1):e189.","journal-title":"Oncogenesis"},{"issue":"11","key":"2656_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.trecan.2019.09.007","volume":"5","author":"B PECK","year":"2019","unstructured":"Peck B. Lipid metabolism at the Nexus of diet and tumor microenvironment [J]. Trends cancer. 2019;5(11):693\u2013703.","journal-title":"Trends cancer"},{"issue":"5","key":"2656_CR7","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/jdv.12298","volume":"28","author":"C ZOUBOULIS C","year":"2014","unstructured":"Zouboulis CC, Jourdan E. Acne is an inflammatory disease and alterations of Sebum composition initiate acne lesions [J]. J Eur Acad Dermatology Venereology: JEADV. 2014;28(5):527\u201332.","journal-title":"J Eur Acad Dermatology Venereology: JEADV"},{"issue":"1","key":"2656_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.plipres.2012.10.003","volume":"52","author":"NICOLAOUA KENDALL A C","year":"2013","unstructured":"Kendall AC, Nicolaou A. Bioactive lipid mediators in skin inflammation and immunity [J]. Prog Lipid Res. 2013;52(1):141\u201364.","journal-title":"Prog Lipid Res"},{"key":"2656_CR9","unstructured":"Zhang L. (2018). Research on Xiao\u2019er Weisheng Zongwei Lun Fang from the Southern Song Dynasty [Doctoral dissertation].&#8203."},{"key":"2656_CR10","first-page":"222","volume":"04","author":"XL Liu","year":"1995","unstructured":"Liu XL, Cui MX, Jin JY, et al. Study on the effect of bear bile powder on hyperlipidemia model in rabbits. J Yanbian Agricultural Coll. 1995;04:222\u20135.","journal-title":"J Yanbian Agricultural Coll"},{"issue":"02","key":"2656_CR11","first-page":"33","volume":"14","author":"Q Wang","year":"2023","unstructured":"Wang Q, Zhang JH, Guo GP, et al. Study on the spectrum-effect relationship and molecular Docking of the lipid-lowering effect of freeze-dried bear bile powder. Traditional Chin Med Clin. 2023;14(02):33\u20138.","journal-title":"Traditional Chin Med Clin"},{"key":"2656_CR12","first-page":"32","volume":"01","author":"ZF Wu","year":"1993","unstructured":"Wu ZF, Xiong CM, Li JS. Preliminary study on the lipid-lowering effect of bear bile powder. Pharmacol Clin Chin Materia Med. 1993;01:32\u20133.","journal-title":"Pharmacol Clin Chin Materia Med"},{"issue":"10","key":"2656_CR13","first-page":"2380","volume":"32","author":"J Wu","year":"2021","unstructured":"Wu J, Wu L, Lou Y, et al. Study on the effect of compound bear bile Yinchen granules on the colon and intestinal microbiota of rats with non-alcoholic fatty liver disease. Shizhen Traditional Chin Med Materia Med. 2021;32(10):2380\u20133.","journal-title":"Shizhen Traditional Chin Med Materia Med"},{"key":"2656_CR14","unstructured":"Zhang L. (2017). Clinical intervention study of ursodeoxycholic acid in non-alcoholic fatty liver disease [Doctoral dissertation]."},{"issue":"29","key":"2656_CR15","doi-asserted-by":"publisher","first-page":"9952","DOI":"10.3748\/wjg.v20.i29.9952","volume":"20","author":"C WANG D Q, CAREY M","year":"2014","unstructured":"Wang DQ, Carey MC. Therapeutic uses of animal biles in traditional Chinese medicine: an ethnopharmacological, biophysical chemical and medicinal review [J]. World J Gastroenterol. 2014;20(29):9952\u201375.","journal-title":"World J Gastroenterol"},{"key":"2656_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1746-4269-5-2","volume":"5","author":"Y FENG","year":"2009","unstructured":"Feng Y, Siu K, Wang N, et al. Bear bile: dilemma of traditional medicinal use and animal protection [J]. J Ethnobiol Ethnomed. 2009;5:2.","journal-title":"J Ethnobiol Ethnomed"},{"issue":"16","key":"2656_CR17","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1007\/s00018-008-7568-6","volume":"65","author":"LR HOFMANN A F, HAGEY","year":"2008","unstructured":"Hofmann AF, Hagey LR. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics [J]. Cell Mol Life Sci. 2008;65(16):2461\u201383.","journal-title":"Cell Mol Life Sci"},{"issue":"Suppl 1","key":"2656_CR18","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S2210-7401(12)70015-3","volume":"36","author":"R POUPON","year":"2012","unstructured":"Poupon R. Ursodeoxycholic acid and bile-acid mimetics as therapeutic agents for cholestatic liver diseases: an overview of their mechanisms of action [J]. Clin Res Hepatol Gastroenterol. 2012;36(Suppl 1):S3\u201312.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"5","key":"2656_CR19","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jhep.2010.08.030","volume":"54","author":"V RATZIU","year":"2011","unstructured":"Ratziu V, De Ledinghen V, Oberti F, et al. A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis [J]. J Hepatol. 2011;54(5):1011\u20139.","journal-title":"J Hepatol"},{"issue":"17","key":"2656_CR20","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1021\/jm025529g","volume":"45","author":"R PELLICCIARI","year":"2002","unstructured":"Pellicciari R, Fiorucci S. 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity [J]. J Med Chem. 2002;45(17):3569\u201372.","journal-title":"J Med Chem"},{"key":"2656_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnmol.2018.00010","volume":"11","author":"TRACEY T J","year":"2018","unstructured":"Tracey TJ, Steyn FJ, Wolvetang EJ, et al. Neuronal lipid metabolism: multiple pathways driving functional outcomes in health and disease [J]. Front Mol Neurosci. 2018;11:10.","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"2656_CR22","doi-asserted-by":"publisher","first-page":"4063","DOI":"10.1111\/jcmm.14293","volume":"23","author":"B SHEN","year":"2019","unstructured":"Shen B, Zhao C, Wang Y, et al. Aucubin inhibited lipid accumulation and oxidative stress via Nrf2\/HO-1 and AMPK signalling pathways [J]. J Cell Mol Med. 2019;23(6):4063\u201375.","journal-title":"J Cell Mol Med"},{"issue":"SupplSuppl","key":"2656_CR23","doi-asserted-by":"publisher","first-page":"S138","DOI":"10.1194\/jlr.R800079-JLR200","volume":"50","author":"SJ WAKIL","year":"2009","unstructured":"Wakil SJ, Abu-Elheiga LA. Fatty acid metabolism: target for metabolic syndrome [J]. J Lipid Res. 2009;50(SupplSuppl):S138\u201343.","journal-title":"J Lipid Res"},{"issue":"10","key":"2656_CR24","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA MENENDEZ","year":"2007","unstructured":"Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis [J]. Nat Rev Cancer. 2007;7(10):763\u201377.","journal-title":"Nat Rev Cancer"},{"key":"2656_CR25","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-nutr-071812-161139","volume":"33","author":"TRIPATHYS JUMP D B","year":"2013","unstructured":"Jump DB, Tripathy S, Depner CM. Fatty acid-regulated transcription factors in the liver [J]. Annu Rev Nutr. 2013;33:249\u201369.","journal-title":"Annu Rev Nutr"},{"issue":"5","key":"2656_CR26","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1021\/acs.nanolett.3c04352","volume":"24","author":"W ZHOU","year":"2024","unstructured":"Zhou W, Lew B, Choi H, et al. Chenodeoxycholic Acid-Loaded nanoparticles are sufficient to decrease adipocyte size by inducing mitochondrial function [J]. Nano Lett. 2024;24(5):1642\u20139.","journal-title":"Nano Lett"},{"key":"2656_CR27","doi-asserted-by":"publisher","first-page":"102452","DOI":"10.1016\/j.redox.2022.102452","volume":"56","author":"J LIU","year":"2022","unstructured":"Liu J, Wei Y, Jia W, et al. Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS\/p38 MAPK\/DGAT1 pathway and inhibiting M2 macrophage polarization [J]. Redox Biol. 2022;56:102452.","journal-title":"Redox Biol"},{"issue":"5","key":"2656_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.2340\/00015555-1802","volume":"94","author":"JS JUNG J Y, KWON H H, HONG","year":"2014","unstructured":"Jung JY, Kwon HH, Hong JS, et al. Effect of dietary supplementation with omega-3 fatty acid and gamma-linolenic acid on acne vulgaris: a randomised, double-blind, controlled trial [J]. Acta dermato-venereologica. 2014;94(5):521\u20135.","journal-title":"Acta dermato-venereologica"},{"issue":"12","key":"2656_CR29","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrc4016","volume":"15","author":"CL WATSON P A, ARORA V K, SAWYERS","year":"2015","unstructured":"Watson PA, Arora VK, Sawyers CL. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer [J]. Nat Rev Cancer. 2015;15(12):701\u201311.","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"2656_CR30","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1101\/gad.1965810","volume":"24","author":"MM SHEN","year":"2010","unstructured":"Shen MM, Abate-Shen C. Molecular genetics of prostate cancer: new prospects for old challenges [J]. Genes Dev. 2010;24(18):1967\u20132000.","journal-title":"Genes Dev"},{"issue":"5","key":"2656_CR31","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0016-5085(03)00262-2","volume":"124","author":"K KATAYAMA","year":"2003","unstructured":"Katayama K, Wada K, Nakajima A, et al. A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model [J]. Gastroenterology. 2003;124(5):1315\u201324.","journal-title":"Gastroenterology"}],"updated-by":[{"DOI":"10.1186\/s12944-025-02752-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000}}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02656-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02656-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02656-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T05:54:15Z","timestamp":1760507655000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02656-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2656"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02656-w","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"2 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: the authors updated Figure 4A (Day 0) and Figure 4H.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12944-025-02752-x","URL":"https:\/\/doi.org\/10.1186\/s12944-025-02752-x","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"238"}}